Fabienne Saint Preux, MD
Pain Medicine · Owensboro, KYNPI 1689108524
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,893 of the $6,468 with a category attached, or 60.2%. Medtronic accounts for 68.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $3,211 and has fallen 72.1% since, to $895 in 2025.
Across 77 payments — averaging $84.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$975
- SPR Therapeutics, Inc$325
- Stryker$277
- Nevro Corp.$272
- Medical Device Business Services, Inc.$98
- plus $123 from 4 others
What the payments were for
- Travel & lodging$3,89360%
- Food & beverage$2,47738%
- Education$982%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 51 | $4,398 |
| Abbott | 8 | $975 |
| SPR Therapeutics, Inc | 5 | $325 |
| Stryker | 3 | $277 |
| Nevro Corp. | 4 | $272 |
| Medical Device Business Services, Inc. | 1 | $98 |
| Boston Scientific | 2 | $50 |
| Lilly USA, LLC | 1 | $26 |
| Amgen | 1 | $26 |
| Saluda Medical Americas, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$1,802
- KYPHON EXPRESS II KYPHOPAK TRAY$1,272
- PROCLAIM$861
- OPTABLATE$229
- SPINEJACK$229
- Senza$143
- SPRINT PNS System$129
- VANTA ADAPTIVESTIM$114
How this compares
$6,468 in reported general payments places this provider in the 60th percentile of 90 pain medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 33 | $400 |
| Gabapentin | 19 | $105 |
| Tramadol Hcl | 16 | $57 |
| Diazepam | 22 | $16 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Owensboro
- Anjum BuxDanville$595K
- Christopher MallardLexington$47K
- Vinod MuniswamyGeorgetown$39K
- John RuxerPaducah$33K
- Timothy BeachamLouisville$31K
- Mazhar RasulLexington$30K
- Tejas ShahAshland$23K
- Lance HoffmanFlorence$22K
- Jonathan GraingerFlorence$22K
- Lasha EsebuaHenderson$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.